Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of HEP® (Homeostasis-Enrichment-Plasticity) Tele-Rehabilitation for Preterm Infants at Developmental Risk

NCT07727733 is registered in ClinicalTrials.gov with Medipol University as lead sponsor.

NCT NCT07727733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07727733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of HEP® (Homeostasis-Enrichment-Plasticity) Tele-Rehabilitation for Preterm Infants at Developmental Risk
Lead sponsor
Medipol University
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2024
Completion date
April 1, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preterm infants at developmental risk